Syros is focused on developing medicines for cancer and immune-mediated diseases with the potential to provide a profound and durable benefit for currently underserved patients.

Syros is seeking strategic collaborations to maximize the value of our programs and to extend the potential of our gene control platform across multiple therapeutic areas and diseases. For our programs, we are focused on partnerships that could expand our geographic reach and allow us to expand into additional indications. For our platform, we are seeking target and drug discovery collaborations that allow us to leverage the potential of our platform in cancers and other serious diseases beyond those that we can address on our own. We also believe that our platform provides significant optionality for collaborations around therapeutic modalities and target classes that fall outside of our current focus on small molecule drugs targeting transcriptional and regulatory proteins.


Contact us at to learn more about partnership opportunities.